Alternative responses of primary tumor cells and glioblastoma cell lines to N,N-bis-(8-hydroxyquinoline-5-yl methyl)-benzyl substituted amines: Cell death versus P53-independent senescence

International Journal of Oncology

Volumn 37, Issue 6, 2010, Pages 1463-1470

  Kraus, Jean Louis ^a,b   Conti, Filippo ^a   Madonna, Sébastien ^a,b   Tchoghandjian, Aurelie ^c   Beclin, Christophe ^a  

^a CNRS   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Cell death; Glioblastoma; HQNBA; P53; Senescence

Indexed keywords

AMINE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; CATHEPSIN B; CATHEPSIN D; CYSTEINE; JLK 1486; PROTEIN P53; SHORT HAIRPIN RNA; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CLONING; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; TUMOR CELL;

AMINES; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL AGING; CELL CULTURE TECHNIQUES; CELL DEATH; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; GLIOBLASTOMA; HUMANS; HYDROXYQUINOLINES; RECEPTORS, CXCR4; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78649934087     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000798     Document Type: Article

References (37)

1. Moret V, Laras Y, Cresteil T, Aubert G, Ping DQ, Di C, Barthélémy-Requin M, Beclin C, Peyrot V, Allegro D, Rolland A, De Angelis F, Gatti E, Pierre P, Pasquini L, Petrucci E, Testa U and Kraus JL: Discovery of a new family of bis-8-hydroxyquinoline substituted benzylamines with pro-apoptotic activity in cancer cells: synthesis, structure-activity relationship, and action mechanism studies. Eur J Med Chem 44: 558-567, 2009.
2. Madonna S, Beclin C, Laras Y, Moret V, Marcowycz A, Lamoral-Theys D, Dubois J, Barthelemy-Requin M, Lenglet G, Depauw S, Cresteil T, Aubert G, Monnier V, Kiss R, David-Cordonnier MH and Kraus JL: Structure-activity relationships and mechanism of action of antitumor bis 8-hydroxyquinoline substituted benzylamines. Eur J Med Chem 45: 623-638, 2010.
3. Millau JF, Bastien N and Drouin R: P53 transcriptional activities: a general overview and some thoughts. Mutat Res 681: 118-133, 2009.
4. Levine AJ: P53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
5. Lane DP: P53, guardian of the genome. Nature 359: 486-487, 1992.
6. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC and Hainaut P: The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19: 607-614, 2002.
7. Hermisson M, Klumpp A, Wick W, Wischhusen J, Nagel G, Roos W, Kaina B and Weller M: O6-methylguanine DNA methyltransferase and P53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem 96: 766-776, 2006.
8. Roos WP, Batista LF, Naumann SC, Wick W, Weller M, Menck CF and Kaina B: Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 26: 186-197, 2007.
9. Batista LF, Roos WP, Christmann M, Menck CF and Kaina B: Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: P53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks. Cancer Res 67: 11886-11895, 2007.
10. Watanabe-Fukunaga R, Iida S, Shimizu Y, Nagata S and Fukunaga R: SEI family of nuclear factors regulates P53-dependent transcriptional activation. Genes Cells 10: 851-860, 2005.
11. Yugawa T, Handa K, Narisawa-Saito M, Ohno S, Fujita M and Kiyono T: Regulation of Notch1 gene expression by P53 in epithelial cells. Mol Cell Biol 27: 3732-3742, 2007. (Pubitemid 46726180)
12. Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, Kalinski H, Gorodin S, Fishman A, Chajut A, Einat P, Skaliter R, Gudkov AV, Chumakov PM and Feinstein E: Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene 21: 6017-6031, 2002.
13. Maiuri MC, Malik SA, Morselli E, Kepp O, Criollo A, Mouchel PL, Carnuccio R and Kroemer G: Stimulation of autophagy by the P53 target gene Sestrin2. Cell Cycle 8: 1571-1576, 2009.
14. Liu T, Laurell C, Selivanova G, Lundeberg J, Nilsson P and Wiman KG: Hypoxia induces P53-dependent transactivation and Fas/CD95-dependent apoptosis. Cell Death Differ 14: 411-421, 2007. (Pubitemid 46259949)
15. Zu K, Bihani T, Lin A, Park YM, Mori K and Ip C: Enhanced selenium effect on growth arrest by BiP/GRP78 knockdown in P53-null human prostate cancer cells. Oncogene 25: 546-554, 2006.
16. Quick QA and Gewirtz DA: An accelerated senescence response to radiation in wild-type P53 glioblastoma multiforme cells. J Neurosurg 105: 111-118, 2006.
17. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C and Lowe SW: Senescence and tumour clearance is triggered by P53 restoration in murine liver carcinomas. Nature 445: 656-660, 2007.
18. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C and Pandolfi PP: Crucial role of P53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730, 2005. (Pubitemid 41117277)
19. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleder R and Jacks T: Restoration of P53 function leads to tumour regression in vivo. Nature 445: 661-665, 2007. (Pubitemid 46232887)
20. Lin HK, Chen Z, Wang G, Nardella C, Lee SW, Chan CH, Yang WL, Wang J, Egia A, Nakayama KI, Cordon-Cardo C, Teruya-Feldstein J and Pandolfi PP: Skp2 targeting suppresses tumorigenesis by Arf-P53-independent cellular senescence. Nature 464: 374-379, 2010.
21. Tchoghandjian A, Baeza N, Colin C, Cayre M, Metellus P, Beclin C, Ouafik L and Figarella-Branger D: A2B5 cells from human glioblastoma have cancer stem cell properties. Brain Pathol 20: 211-221, 2010.
22. Erdal H, Berndtsson M, Castro J, Brunk U, Shoshan MC and Linder S: Induction of lysosomal membrane permeabilization by compounds that activate P53-independent apoptosis. Proc Natl Acad Sci USA 102: 192-197, 2005.
23. Garino C, Tomita T, Pietrancosta N, Laras Y, Rosas R, Herbette G, Maigret B, Quéléver G, Iwatsubo T and Kraus JL: Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays. J Med Chem 49: 4275-4285, 2006.
24. Lefranc F, Facchini V and Kiss R: Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 12: 1395-1403, 2007.
25. Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT and Brock C: Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 23: 35-61, 1997.
26. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E and Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
27. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y and Kondo S: Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11: 448-457, 2004. (Pubitemid 38489422)
28. Martinkova E, Maglott A, Leger DY, Bonnet D, Stiborova M, Takeda K, Martin S and Dontenwill M: alpha5beta1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells. Int J Cancer 127: 1240-1248, 2010.
29. Guo GE, Ma LW, Jiang B, Yi J, Tong TJ and Wang WG: Hydrogen peroxide induces p16(INK4a) through an AUF1-dependent manner. J Cell Biol 109: 1000-1005, 2010.
30. Wu Y, Zhang H, Dong Y, Park YM and Ip C: Endoplasmic reticulum stress signal mediators are targets of selenium action. Cancer Res 65: 9073-9079, 2005.
31. Linder S and Shoshan MC: Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy. Drug Resist Updat 8: 199-204, 2005. (Pubitemid 41446963)
32. Schönthal AH: Endoplasmic reticulum stress and autophagy as targets for cancer therapy. Cancer Lett 275: 163-169, 2009.
33. Kardosh A, Golden EB, Pyrko P, Uddin J, Hofman FM, Chen TC, Louie SG, Petasis NA and Schönthal AH: Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. Cancer Res 68: 843-851, 2008. (Pubitemid 351206762)
34. Chen TC, Lai KC, Yang JS, Liao CL, Hsia TC, Chen GW, Lin JJ, Lin HJ, Chiu TH, Tang YJ and Chung JG: Involvement of reactive oxygen species and caspase-dependent pathway in berberine-induced cell cycle arrest and apoptosis in C6 rat glioma cells. Int J Oncol 34: 1681-1690, 2009.
35. Salazar M, Carracedo A, Salanueva IJ, Hernández-Tiedra S, Lorente M, Egia A, Vázquez P, Blázquez C, Torres S, García S, Nowak J, Fimia GM, Piacentini M, Cecconi F, Pandolfi PP, González-Feria L, Iovanna JL, Guzmán M, Boya P and Velasco G: Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 119: 1359-1372, 2009.
36. Bursch W: The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 8: 569-581, 2001.
37. Bröker LE, Kruyt FA and Giaccone G: Cell death independent of caspases: a review. Clin Cancer Res 11: 3155-3162, 2005.